1969
DOI: 10.1378/chest.56.4.279
|View full text |Cite
|
Sign up to set email alerts
|

Direct Myocardial Revascularization with Saphenous Vein Autograft

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
16
0
3

Year Published

1970
1970
2014
2014

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(19 citation statements)
references
References 2 publications
0
16
0
3
Order By: Relevance
“…In addition, our observation may also have important clinical implications for understanding pathological process of venous graft diseases. Autologous saphenous veins are widely used to circumvent occluded coronary arteries during coronary artery bypass grafting procedures in order to treat myocardial ischemic diseases [30]. Venous graft is susceptible to accelerated atherosclerosis and narrowing of the vessel lumen.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, our observation may also have important clinical implications for understanding pathological process of venous graft diseases. Autologous saphenous veins are widely used to circumvent occluded coronary arteries during coronary artery bypass grafting procedures in order to treat myocardial ischemic diseases [30]. Venous graft is susceptible to accelerated atherosclerosis and narrowing of the vessel lumen.…”
Section: Discussionmentioning
confidence: 99%
“…Patients with myocardial infarction, acute myo-pericarditis, chronic rheumatic heart disease, or following cardiac surgery have augmented rates of AF. In fact, for the patients following coronary bypass grafting, the link has been noted since the report of the first 100 cases was published in 1969[31]; the initial incidence reported in that paper was 12% but has since been demonstrated to be 17-33% (and higher in valvular or hybrid procedures[32]. Multiple inflammatory markers have been linked with a propensity towards AF, including several of the interleukins (IL-2, IL-6, and IL-8), as well as C-reactive protein (CRP), tissue necrosis factor-alpha (TNF-α), and monocyte chemoattractant protein-1 (MCP-1)[33].…”
Section: Mechanismsmentioning
confidence: 99%
“…11 This procedure seems to be very promising; however, we should reserve our enthusiasm until further data and controlled studies are forthcoming and have been carefully analyzed.…”
Section: Preinfarction Anginamentioning
confidence: 99%